1. Home
  2. KALA vs YCBD Comparison

KALA vs YCBD Comparison

Compare KALA & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.68

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo cbdMD Inc.

YCBD

cbdMD Inc.

HOLD

Current Price

$1.20

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALA
YCBD
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KALA
YCBD
Price
$0.68
$1.20
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$31.50
$2.00
AVG Volume (30 Days)
21.5M
1.0M
Earning Date
11-19-2025
12-15-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$19,026,064.00
Revenue This Year
N/A
$0.37
Revenue Next Year
N/A
$4.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.47
52 Week High
$20.60
$6.54

Technical Indicators

Market Signals
Indicator
KALA
YCBD
Relative Strength Index (RSI) 36.22 76.93
Support Level $0.67 $0.60
Resistance Level $0.86 $0.67
Average True Range (ATR) 0.24 0.11
MACD 0.09 0.06
Stochastic Oscillator 5.09 71.23

Price Performance

Historical Comparison
KALA
YCBD

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: